ITRI ITRON, INC.
Q3 2025 10-Q
Filed: Oct 30, 2025Period ending Sep 30, 2025
Health Care
Instruments For Meas & Testing of Electricity & Elec SignalsSEC EDGAR ITRON, INC. (ITRI) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 30, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Risk Factors
- • Newly added acquisition risk: Urbint, Inc. merger agreement signed Oct 6, 2025 for $325M cash, expected closing Q4 2025
- • Materially updated debt facility: new $750M revolving credit, maturity Sept 25, 2030 with potential acceleration to Apr 15, 2030
Quarterly Financial SummaryXBRL
Revenue
$582M
Net Income
$66M
Gross Margin
37.7%
Operating Margin
14.1%
Net Margin
11.3%
ROE
3.9%
Total Assets
$3.7B
Source: XBRL data from ITRON, INC. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on ITRON, INC.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.